Epigen Therapeutics is a biopharmaceutical company, headquartered in Italy, focused on providing novel diagnostic and therapeutic tools in the field of Immuno-Oncology to improve the comprehensive clinical management of cancer patients.

The core activity of Epigen Therapeutics is the development and commercialization of a proprietary, world-wide patented, platform of highly innovative anticancer agents.

Epigen Therapeutics also develops pre-clinical and clinical projects with industrial and academic partners, as well as scientific consultancies. The competencies of Epigen Therapeutics rely on its strong expertise in the fields of cancer epigenetics, tumor immunology and immunotherapy that span from the bench to the bedside.